Raclopride clinical trials
- studies test it
- 3
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses Raclopride is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2014 (1)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2017 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 0 · Other 3
National Institute on Alcohol Abuse and Alcoholism (NIAAA) (1) · National Institute of Neurological Disorders and Stroke (NINDS) (1) · National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (1)
Related medicines
As reviewed, each with the page that says it.
- One of Antipsychotics source
Studies
Open first, then newest update. How each study uses Raclopride is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Brain Dopaminergic Signaling in Opioid Use DisordersCompletedEarly Phase 1National Institute on Alcohol Abuse and Alcoholism (NIAAA)NCT03190954Written as [11C]raclopride plus drug
- Neural Basis of Decision-Making Deficits in Traumatic Brain InjuryCompletedPhase 1National Institute of Neurological Disorders and Stroke (NINDS)NCT02169310Written as [11C] Raclopride
- Brain Dopamine Function in Human ObesityCompletedEarly Phase 1National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT03648892Written as [c11] raclopride
Given beside what is tested · 2 — Raclopride is usual care or a partner of the new treatment
- Effects of Ad Libitum Ultra-Processed Diet on Brain Dopamine in HumansNot yet recruitingNot applicableNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NCT07920952Written as [11C] raclopride
- Examining the Effects of Estradiol on Neural and Molecular Response to RewardRecruitingPhase 4University of North Carolina, Chapel HillNCT05282277Written as Raclopride C11
Codes
What other systems call Raclopride · ClinicalTrials.gg INT008777
- MeSH (NLM) D020891RacloprideConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 430K3SOZ7GRACLOPRIDEConfirmed FDA, NLM, Wikidata
- Wikidata Q7279814racloprideConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C152139RacloprideOne source FDA
- DrugBank DB12518One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D020891 | Raclopride | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 430K3SOZ7G | RACLOPRIDE | Confirmed FDA, NLM, Wikidata |
| Wikidata | Q7279814 | raclopride | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C152139 | Raclopride | One source FDA |
| DrugBank | DB12518 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.